Growth Metrics

Gilead Sciences (GILD) Gross Margin (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -27.00
Dec 31, 2025 -30.00
Sep 30, 2025 100.00
Jun 30, 2025 190.00
Mar 31, 2025 -221.00
Dec 31, 2024 -3.00
Sep 30, 2024 134.00
Jun 30, 2024 101.00
Mar 31, 2024 617.00
Dec 31, 2023 -718.00
Sep 30, 2023 -34.00
Jun 30, 2023 20.00
Mar 31, 2023 -316.00
Dec 31, 2022 92.00
Sep 30, 2022 323.00
Jun 30, 2022 -143.00
Mar 31, 2022 1,466.00
Dec 31, 2021 -1,978.00
Sep 30, 2021 588.00
Jun 30, 2021 -117.00
Mar 31, 2021 -235.00
Dec 31, 2020 -149.00
Sep 30, 2020 334.00
Jun 30, 2020 -322.00
Mar 31, 2020 1,116.00
Dec 31, 2019 -1,016.00
Sep 30, 2019 -88.00
Jun 30, 2019 53.00
Mar 31, 2019 897.00
Dec 31, 2018 -769.00
Sep 30, 2018 177.00
Jun 30, 2018 -150.00
Mar 31, 2018 144.00
Dec 31, 2017 -527.00
Sep 30, 2017 -8.00
Jun 30, 2017 -106.00
Mar 31, 2017 -3.00
Dec 31, 2016 37.00
Sep 30, 2016 -394.00
Jun 30, 2016 420.00
Mar 31, 2016 -282.00
Dec 31, 2015 34.00
Sep 30, 2015 -72.00
Jun 30, 2015 -49.00
Mar 31, 2015 292.00
Dec 31, 2014 180.00
Sep 30, 2014 -218.00
Jun 30, 2014 211.00
Mar 31, 2014 1,124.00
Dec 31, 2013 -36.00
Sep 30, 2013 157.00
Jun 30, 2013 182.00
Mar 31, 2013 -443.00
Dec 31, 2012 134.00
Sep 30, 2012 172.00
Jun 30, 2012 -46.00
Mar 31, 2012 -214.00
Dec 31, 2011 114.00
Sep 30, 2011 184.00
Jun 30, 2011 -169.00
Mar 31, 2011 -303.00
Dec 31, 2010 -19.00
Sep 30, 2010 -101.00
Jun 30, 2010 -252.00
Mar 31, 2010 218.00
Dec 31, 2009 -55.00
Sep 30, 2009 51.00
Jun 30, 2009 -173.00